However, although oxytocin and carbetocin are both recommended as prophylactic agents in treating PPH, their use is limited mostly due to their stability issues and refrigeration requirements which may not be feasible in many of the remote regions of Southeast Asian countries [31,37]. Here, OXT is linked to pulmonary arterial hypertension.